The relevance of BRAF G469A mutation in determining the response to therapy in metastatic melanoma

Gespeichert in:

Autor*in:	Porcelli, Letizia [verfasserIn] Guida, Gabriella Cocco, Tiziana Quatrale, Anna E. Iacobazzi, Rosa M Stolfa, Diana A Maida, Imma Ferretta, Anna Grieco, Claudia Guida, Stefania Strippoli, Sabino Tommasi, Stefania Guida, Michele Azzariti, Amalia

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	2015

Schlagwörter:	Metastatic Melanoma Vemurafenib BRAF Inhibitor Dabrafenib BRAF Gene

Anmerkung:	© Porcelli et al; licensee BioMed Central Ltd. 2015. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (

Übergeordnetes Werk:	Enthalten in: Journal of translational medicine - London : BioMed Central, 2003, 13(2015), Suppl 1 vom: 15. Jan.
Übergeordnetes Werk:	volume:13 ; year:2015 ; number:Suppl 1 ; day:15 ; month:01

Links:	Volltext

DOI / URN:	10.1186/1479-5876-13-S1-P3

Katalog-ID:	SPR028959027

Internformat


LEADER	01000caa a22002652 4500
001	SPR028959027
003	DE-627
005	20230519104530.0
007	cr uuu---uuuuu
008	201007s2015 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.1186/1479-5876-13-S1-P3 \|2 doi
035			\|a (DE-627)SPR028959027
035			\|a (SPR)1479-5876-13-S1-P3-e
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
100	1		\|a Porcelli, Letizia \|e verfasserin \|4 aut
245	1	4	\|a The relevance of BRAF G469A mutation in determining the response to therapy in metastatic melanoma
264		1	\|c 2015
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a © Porcelli et al; licensee BioMed Central Ltd. 2015. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (
650		4	\|a Metastatic Melanoma \|7 (dpeaa)DE-He213
650		4	\|a Vemurafenib \|7 (dpeaa)DE-He213
650		4	\|a BRAF Inhibitor \|7 (dpeaa)DE-He213
650		4	\|a Dabrafenib \|7 (dpeaa)DE-He213
650		4	\|a BRAF Gene \|7 (dpeaa)DE-He213
700	1		\|a Guida, Gabriella \|4 aut
700	1		\|a Cocco, Tiziana \|4 aut
700	1		\|a Quatrale, Anna E. \|4 aut
700	1		\|a Iacobazzi, Rosa M \|4 aut
700	1		\|a Stolfa, Diana A \|4 aut
700	1		\|a Maida, Imma \|4 aut
700	1		\|a Ferretta, Anna \|4 aut
700	1		\|a Grieco, Claudia \|4 aut
700	1		\|a Guida, Stefania \|4 aut
700	1		\|a Strippoli, Sabino \|4 aut
700	1		\|a Tommasi, Stefania \|4 aut
700	1		\|a Guida, Michele \|4 aut
700	1		\|a Azzariti, Amalia \|4 aut
773	0	8	\|i Enthalten in \|t Journal of translational medicine \|d London : BioMed Central, 2003 \|g 13(2015), Suppl 1 vom: 15. Jan. \|w (DE-627)369084136 \|w (DE-600)2118570-0 \|x 1479-5876 \|7 nnns
773	1	8	\|g volume:13 \|g year:2015 \|g number:Suppl 1 \|g day:15 \|g month:01
856	4	0	\|u https://dx.doi.org/10.1186/1479-5876-13-S1-P3 \|z lizenzpflichtig \|3 Volltext
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_SPRINGER
912			\|a SSG-OLC-PHA
912			\|a GBV_ILN_11
912			\|a GBV_ILN_20
912			\|a GBV_ILN_22
912			\|a GBV_ILN_23
912			\|a GBV_ILN_24
912			\|a GBV_ILN_31
912			\|a GBV_ILN_39
912			\|a GBV_ILN_40
912			\|a GBV_ILN_60
912			\|a GBV_ILN_62
912			\|a GBV_ILN_63
912			\|a GBV_ILN_65
912			\|a GBV_ILN_69
912			\|a GBV_ILN_73
912			\|a GBV_ILN_74
912			\|a GBV_ILN_95
912			\|a GBV_ILN_105
912			\|a GBV_ILN_110
912			\|a GBV_ILN_151
912			\|a GBV_ILN_161
912			\|a GBV_ILN_170
912			\|a GBV_ILN_206
912			\|a GBV_ILN_213
912			\|a GBV_ILN_230
912			\|a GBV_ILN_285
912			\|a GBV_ILN_293
912			\|a GBV_ILN_602
912			\|a GBV_ILN_2003
912			\|a GBV_ILN_2005
912			\|a GBV_ILN_2009
912			\|a GBV_ILN_2011
912			\|a GBV_ILN_2014
912			\|a GBV_ILN_2055
912			\|a GBV_ILN_2111
912			\|a GBV_ILN_4012
912			\|a GBV_ILN_4037
912			\|a GBV_ILN_4112
912			\|a GBV_ILN_4125
912			\|a GBV_ILN_4126
912			\|a GBV_ILN_4249
912			\|a GBV_ILN_4305
912			\|a GBV_ILN_4306
912			\|a GBV_ILN_4307
912			\|a GBV_ILN_4313
912			\|a GBV_ILN_4322
912			\|a GBV_ILN_4323
912			\|a GBV_ILN_4324
912			\|a GBV_ILN_4325
912			\|a GBV_ILN_4338
912			\|a GBV_ILN_4367
912			\|a GBV_ILN_4700
951			\|a AR
952			\|d 13 \|j 2015 \|e Suppl 1 \|b 15 \|c 01

Indexfelder

author_variant	l p lp g g gg t c tc a e q ae aeq r m i rm rmi d a s da das i m im a f af c g cg s g sg s s ss s t st m g mg a a aa
matchkey_str	article:14795876:2015----::hrlvnefrf49mttoidtriighrsosttea
hierarchy_sort_str	2015
publishDate	2015
allfields	10.1186/1479-5876-13-S1-P3 doi (DE-627)SPR028959027 (SPR)1479-5876-13-S1-P3-e DE-627 ger DE-627 rakwb eng Porcelli, Letizia verfasserin aut The relevance of BRAF G469A mutation in determining the response to therapy in metastatic melanoma 2015 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Porcelli et al; licensee BioMed Central Ltd. 2015. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( Metastatic Melanoma (dpeaa)DE-He213 Vemurafenib (dpeaa)DE-He213 BRAF Inhibitor (dpeaa)DE-He213 Dabrafenib (dpeaa)DE-He213 BRAF Gene (dpeaa)DE-He213 Guida, Gabriella aut Cocco, Tiziana aut Quatrale, Anna E. aut Iacobazzi, Rosa M aut Stolfa, Diana A aut Maida, Imma aut Ferretta, Anna aut Grieco, Claudia aut Guida, Stefania aut Strippoli, Sabino aut Tommasi, Stefania aut Guida, Michele aut Azzariti, Amalia aut Enthalten in Journal of translational medicine London : BioMed Central, 2003 13(2015), Suppl 1 vom: 15. Jan. (DE-627)369084136 (DE-600)2118570-0 1479-5876 nnns volume:13 year:2015 number:Suppl 1 day:15 month:01 https://dx.doi.org/10.1186/1479-5876-13-S1-P3 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 13 2015 Suppl 1 15 01
spelling	10.1186/1479-5876-13-S1-P3 doi (DE-627)SPR028959027 (SPR)1479-5876-13-S1-P3-e DE-627 ger DE-627 rakwb eng Porcelli, Letizia verfasserin aut The relevance of BRAF G469A mutation in determining the response to therapy in metastatic melanoma 2015 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Porcelli et al; licensee BioMed Central Ltd. 2015. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( Metastatic Melanoma (dpeaa)DE-He213 Vemurafenib (dpeaa)DE-He213 BRAF Inhibitor (dpeaa)DE-He213 Dabrafenib (dpeaa)DE-He213 BRAF Gene (dpeaa)DE-He213 Guida, Gabriella aut Cocco, Tiziana aut Quatrale, Anna E. aut Iacobazzi, Rosa M aut Stolfa, Diana A aut Maida, Imma aut Ferretta, Anna aut Grieco, Claudia aut Guida, Stefania aut Strippoli, Sabino aut Tommasi, Stefania aut Guida, Michele aut Azzariti, Amalia aut Enthalten in Journal of translational medicine London : BioMed Central, 2003 13(2015), Suppl 1 vom: 15. Jan. (DE-627)369084136 (DE-600)2118570-0 1479-5876 nnns volume:13 year:2015 number:Suppl 1 day:15 month:01 https://dx.doi.org/10.1186/1479-5876-13-S1-P3 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 13 2015 Suppl 1 15 01
allfields_unstemmed	10.1186/1479-5876-13-S1-P3 doi (DE-627)SPR028959027 (SPR)1479-5876-13-S1-P3-e DE-627 ger DE-627 rakwb eng Porcelli, Letizia verfasserin aut The relevance of BRAF G469A mutation in determining the response to therapy in metastatic melanoma 2015 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Porcelli et al; licensee BioMed Central Ltd. 2015. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( Metastatic Melanoma (dpeaa)DE-He213 Vemurafenib (dpeaa)DE-He213 BRAF Inhibitor (dpeaa)DE-He213 Dabrafenib (dpeaa)DE-He213 BRAF Gene (dpeaa)DE-He213 Guida, Gabriella aut Cocco, Tiziana aut Quatrale, Anna E. aut Iacobazzi, Rosa M aut Stolfa, Diana A aut Maida, Imma aut Ferretta, Anna aut Grieco, Claudia aut Guida, Stefania aut Strippoli, Sabino aut Tommasi, Stefania aut Guida, Michele aut Azzariti, Amalia aut Enthalten in Journal of translational medicine London : BioMed Central, 2003 13(2015), Suppl 1 vom: 15. Jan. (DE-627)369084136 (DE-600)2118570-0 1479-5876 nnns volume:13 year:2015 number:Suppl 1 day:15 month:01 https://dx.doi.org/10.1186/1479-5876-13-S1-P3 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 13 2015 Suppl 1 15 01
allfieldsGer	10.1186/1479-5876-13-S1-P3 doi (DE-627)SPR028959027 (SPR)1479-5876-13-S1-P3-e DE-627 ger DE-627 rakwb eng Porcelli, Letizia verfasserin aut The relevance of BRAF G469A mutation in determining the response to therapy in metastatic melanoma 2015 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Porcelli et al; licensee BioMed Central Ltd. 2015. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( Metastatic Melanoma (dpeaa)DE-He213 Vemurafenib (dpeaa)DE-He213 BRAF Inhibitor (dpeaa)DE-He213 Dabrafenib (dpeaa)DE-He213 BRAF Gene (dpeaa)DE-He213 Guida, Gabriella aut Cocco, Tiziana aut Quatrale, Anna E. aut Iacobazzi, Rosa M aut Stolfa, Diana A aut Maida, Imma aut Ferretta, Anna aut Grieco, Claudia aut Guida, Stefania aut Strippoli, Sabino aut Tommasi, Stefania aut Guida, Michele aut Azzariti, Amalia aut Enthalten in Journal of translational medicine London : BioMed Central, 2003 13(2015), Suppl 1 vom: 15. Jan. (DE-627)369084136 (DE-600)2118570-0 1479-5876 nnns volume:13 year:2015 number:Suppl 1 day:15 month:01 https://dx.doi.org/10.1186/1479-5876-13-S1-P3 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 13 2015 Suppl 1 15 01
allfieldsSound	10.1186/1479-5876-13-S1-P3 doi (DE-627)SPR028959027 (SPR)1479-5876-13-S1-P3-e DE-627 ger DE-627 rakwb eng Porcelli, Letizia verfasserin aut The relevance of BRAF G469A mutation in determining the response to therapy in metastatic melanoma 2015 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Porcelli et al; licensee BioMed Central Ltd. 2015. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( Metastatic Melanoma (dpeaa)DE-He213 Vemurafenib (dpeaa)DE-He213 BRAF Inhibitor (dpeaa)DE-He213 Dabrafenib (dpeaa)DE-He213 BRAF Gene (dpeaa)DE-He213 Guida, Gabriella aut Cocco, Tiziana aut Quatrale, Anna E. aut Iacobazzi, Rosa M aut Stolfa, Diana A aut Maida, Imma aut Ferretta, Anna aut Grieco, Claudia aut Guida, Stefania aut Strippoli, Sabino aut Tommasi, Stefania aut Guida, Michele aut Azzariti, Amalia aut Enthalten in Journal of translational medicine London : BioMed Central, 2003 13(2015), Suppl 1 vom: 15. Jan. (DE-627)369084136 (DE-600)2118570-0 1479-5876 nnns volume:13 year:2015 number:Suppl 1 day:15 month:01 https://dx.doi.org/10.1186/1479-5876-13-S1-P3 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 13 2015 Suppl 1 15 01
language	English
source	Enthalten in Journal of translational medicine 13(2015), Suppl 1 vom: 15. Jan. volume:13 year:2015 number:Suppl 1 day:15 month:01
sourceStr	Enthalten in Journal of translational medicine 13(2015), Suppl 1 vom: 15. Jan. volume:13 year:2015 number:Suppl 1 day:15 month:01
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	Metastatic Melanoma Vemurafenib BRAF Inhibitor Dabrafenib BRAF Gene
isfreeaccess_bool	false
container_title	Journal of translational medicine
authorswithroles_txt_mv	Porcelli, Letizia @@aut@@ Guida, Gabriella @@aut@@ Cocco, Tiziana @@aut@@ Quatrale, Anna E. @@aut@@ Iacobazzi, Rosa M @@aut@@ Stolfa, Diana A @@aut@@ Maida, Imma @@aut@@ Ferretta, Anna @@aut@@ Grieco, Claudia @@aut@@ Guida, Stefania @@aut@@ Strippoli, Sabino @@aut@@ Tommasi, Stefania @@aut@@ Guida, Michele @@aut@@ Azzariti, Amalia @@aut@@
publishDateDaySort_date	2015-01-15T00:00:00Z
hierarchy_top_id	369084136
id	SPR028959027
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR028959027</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519104530.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2015 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1186/1479-5876-13-S1-P3</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR028959027</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)1479-5876-13-S1-P3-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Porcelli, Letizia</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="4"><subfield code="a">The relevance of BRAF G469A mutation in determining the response to therapy in metastatic melanoma</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2015</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Porcelli et al; licensee BioMed Central Ltd. 2015. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Metastatic Melanoma</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Vemurafenib</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">BRAF Inhibitor</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Dabrafenib</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">BRAF Gene</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Guida, Gabriella</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cocco, Tiziana</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Quatrale, Anna E.</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Iacobazzi, Rosa M</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Stolfa, Diana A</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Maida, Imma</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ferretta, Anna</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Grieco, Claudia</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Guida, Stefania</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Strippoli, Sabino</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tommasi, Stefania</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Guida, Michele</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Azzariti, Amalia</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Journal of translational medicine</subfield><subfield code="d">London : BioMed Central, 2003</subfield><subfield code="g">13(2015), Suppl 1 vom: 15. Jan.</subfield><subfield code="w">(DE-627)369084136</subfield><subfield code="w">(DE-600)2118570-0</subfield><subfield code="x">1479-5876</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:13</subfield><subfield code="g">year:2015</subfield><subfield code="g">number:Suppl 1</subfield><subfield code="g">day:15</subfield><subfield code="g">month:01</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1186/1479-5876-13-S1-P3</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_11</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2003</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2055</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">13</subfield><subfield code="j">2015</subfield><subfield code="e">Suppl 1</subfield><subfield code="b">15</subfield><subfield code="c">01</subfield></datafield></record></collection>
author	Porcelli, Letizia
spellingShingle	Porcelli, Letizia misc Metastatic Melanoma misc Vemurafenib misc BRAF Inhibitor misc Dabrafenib misc BRAF Gene The relevance of BRAF G469A mutation in determining the response to therapy in metastatic melanoma
authorStr	Porcelli, Letizia
ppnlink_with_tag_str_mv	@@773@@(DE-627)369084136
format	electronic Article
delete_txt_mv	keep
author_role	aut aut aut aut aut aut aut aut aut aut aut aut aut aut
collection	springer
remote_str	true
illustrated	Not Illustrated
issn	1479-5876
topic_title	The relevance of BRAF G469A mutation in determining the response to therapy in metastatic melanoma Metastatic Melanoma (dpeaa)DE-He213 Vemurafenib (dpeaa)DE-He213 BRAF Inhibitor (dpeaa)DE-He213 Dabrafenib (dpeaa)DE-He213 BRAF Gene (dpeaa)DE-He213
topic	misc Metastatic Melanoma misc Vemurafenib misc BRAF Inhibitor misc Dabrafenib misc BRAF Gene
topic_unstemmed	misc Metastatic Melanoma misc Vemurafenib misc BRAF Inhibitor misc Dabrafenib misc BRAF Gene
topic_browse	misc Metastatic Melanoma misc Vemurafenib misc BRAF Inhibitor misc Dabrafenib misc BRAF Gene
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	Journal of translational medicine
hierarchy_parent_id	369084136
hierarchy_top_title	Journal of translational medicine
isfreeaccess_txt	false
familylinks_str_mv	(DE-627)369084136 (DE-600)2118570-0
title	The relevance of BRAF G469A mutation in determining the response to therapy in metastatic melanoma
ctrlnum	(DE-627)SPR028959027 (SPR)1479-5876-13-S1-P3-e
title_full	The relevance of BRAF G469A mutation in determining the response to therapy in metastatic melanoma
author_sort	Porcelli, Letizia
journal	Journal of translational medicine
journalStr	Journal of translational medicine
lang_code	eng
isOA_bool	false
recordtype	marc
publishDateSort	2015
contenttype_str_mv	txt
author_browse	Porcelli, Letizia Guida, Gabriella Cocco, Tiziana Quatrale, Anna E. Iacobazzi, Rosa M Stolfa, Diana A Maida, Imma Ferretta, Anna Grieco, Claudia Guida, Stefania Strippoli, Sabino Tommasi, Stefania Guida, Michele Azzariti, Amalia
container_volume	13
format_se	Elektronische Aufsätze
author-letter	Porcelli, Letizia
doi_str_mv	10.1186/1479-5876-13-S1-P3
title_sort	relevance of braf g469a mutation in determining the response to therapy in metastatic melanoma
title_auth	The relevance of BRAF G469A mutation in determining the response to therapy in metastatic melanoma
abstract	© Porcelli et al; licensee BioMed Central Ltd. 2015. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (
abstractGer	© Porcelli et al; licensee BioMed Central Ltd. 2015. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (
abstract_unstemmed	© Porcelli et al; licensee BioMed Central Ltd. 2015. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700
container_issue	Suppl 1
title_short	The relevance of BRAF G469A mutation in determining the response to therapy in metastatic melanoma
url	https://dx.doi.org/10.1186/1479-5876-13-S1-P3
remote_bool	true
author2	Guida, Gabriella Cocco, Tiziana Quatrale, Anna E. Iacobazzi, Rosa M Stolfa, Diana A Maida, Imma Ferretta, Anna Grieco, Claudia Guida, Stefania Strippoli, Sabino Tommasi, Stefania Guida, Michele Azzariti, Amalia
author2Str	Guida, Gabriella Cocco, Tiziana Quatrale, Anna E. Iacobazzi, Rosa M Stolfa, Diana A Maida, Imma Ferretta, Anna Grieco, Claudia Guida, Stefania Strippoli, Sabino Tommasi, Stefania Guida, Michele Azzariti, Amalia
ppnlink	369084136
mediatype_str_mv	c
isOA_txt	false
hochschulschrift_bool	false
doi_str	10.1186/1479-5876-13-S1-P3
up_date	2024-07-03T22:44:56.855Z
_version_	1803599685209817088
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR028959027</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519104530.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2015 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1186/1479-5876-13-S1-P3</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR028959027</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)1479-5876-13-S1-P3-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Porcelli, Letizia</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="4"><subfield code="a">The relevance of BRAF G469A mutation in determining the response to therapy in metastatic melanoma</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2015</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Porcelli et al; licensee BioMed Central Ltd. 2015. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Metastatic Melanoma</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Vemurafenib</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">BRAF Inhibitor</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Dabrafenib</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">BRAF Gene</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Guida, Gabriella</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cocco, Tiziana</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Quatrale, Anna E.</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Iacobazzi, Rosa M</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Stolfa, Diana A</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Maida, Imma</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ferretta, Anna</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Grieco, Claudia</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Guida, Stefania</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Strippoli, Sabino</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tommasi, Stefania</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Guida, Michele</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Azzariti, Amalia</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Journal of translational medicine</subfield><subfield code="d">London : BioMed Central, 2003</subfield><subfield code="g">13(2015), Suppl 1 vom: 15. Jan.</subfield><subfield code="w">(DE-627)369084136</subfield><subfield code="w">(DE-600)2118570-0</subfield><subfield code="x">1479-5876</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:13</subfield><subfield code="g">year:2015</subfield><subfield code="g">number:Suppl 1</subfield><subfield code="g">day:15</subfield><subfield code="g">month:01</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1186/1479-5876-13-S1-P3</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_11</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2003</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2055</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">13</subfield><subfield code="j">2015</subfield><subfield code="e">Suppl 1</subfield><subfield code="b">15</subfield><subfield code="c">01</subfield></datafield></record></collection>
score	7.4017677

Nicht das Richtige dabei?

Schreiben Sie uns!

The relevance of BRAF G469A mutation in determining the response to therapy in metastatic melanoma

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?